— 研究院科学家及管理团队 —
Research Scientist And Management Team
研究院科学家及管理团队 Research Institute Scientists And Management Team
陈路 董事长
清华大学五道口金融学院全球金融GFD在读博士，东莞市十五届人大常委、东莞市工商联副主席、东莞市青联副主席、广东省浙江商会执行会长、东莞市浙江商会会长、广东名店实业集团有限公司董事长、东莞粤港澳干细胞生物科技有限公司董事长、东莞市恩联干细胞生物科技研究院院长。
Lu Chen, Chairman
Ph.D. Candidate, Global Finance GFD, PBC School of Finance (PBCSF), Tsinghua University
Member of the Standing Committee of the 15th National People's Congress of Dongguan City, Vice-Chairman of Dongguan Federation of Industry and Commerce, Vice-Chairman of Dongguan Youth Federation, Executive Chairman of Zhejiang Chamber of Commerce of Guangdong Province, Chairman of Dongguan Zhejiang Chamber of Commerce, Chairman of GuangDong Mingdian Industrial Group Co., Ltd., Chairman of GHM Stem Cell Biotechnology Co., Ltd., Director of Enlife Stem Cell Biotechnology Institute.
朱奕龙 联席董事长
中国侨联副主席、全国政协委员，银帝集团董事局主席、粤港澳大湾区产融投资有限公司董事局主席兼总裁、东莞粤港澳干细胞生物科技有限公司联席董事长。
YiLong Zhu, Co-Chairman
Vice-Chairman of All-China Federation ofReturnedOverseasChinese,member of the CPPCC National Committee, Chairman of the Board of Directors of YINDI Group, Chairman and President of the Board of Directors of GHM Greater Bay Area Investment Co., Ltd., Co-Chairman of Dongguan GHM Stem Cell Biotechnology Co., Ltd.
谭凤鸣 联合创始人、董事、总经理
毕业于吉林大学，现任广东名店实业集团有限公司副总经理、东莞粤港澳干细胞生物科技有限公司联合创始人、董事、总经理，东莞市恩联干细胞生物科技研究院副理事长。
FengMing Tan, Co-founder, Director & General Manager
Graduated from Jilin University, Ms Tan is now deputy general manager of GuangDong Mingdian Industrial Group Co., Ltd., co-founder, director and general manager of Dongguan GHM Stem Cell Biotechnology Co., Ltd., and Vice Chairman of Dongguan Enlife Stem Cell Biotechnology Institute.
谭蔚泓 院士 学术委员会主任 中国科学院大学附属肿瘤医院（浙江省肿瘤医院）院长
分析化学和化学生物学专家，密歇根大学博士，中国科学院院士，发展中国家科学院院士，973项目首席科学家，长江学者特聘教授，国家“千人计划”特聘教授，国家杰出青年基金（B）获得者，湖南大学副校长，湖南大学生物学院创院院长、教授，湖南大学化学化工学院教授，中国科学院化学研究所分子科学前沿讲座教授，上海交通大学分子医学研究院院长，佛罗里达大学Distinguished Porfessor、V. T. and Louise Jackson Professor of Chemistry，化学生物传感与计量学国家重点实验室（湖南大学）主任，化学生物传感与计量学国家重点实验室（湖南大学）香港浸会大学分室主任，化学生物学创新引智基地（111计划）带头人，化学与分子医学协同创新中心主任，《分析化学前沿》（Analytical Chemistry Frontiers）主编，《美国化学会志》（JACS）副主编，湖南省科学技术协会第十届全省委员会副主席，湖南省院士联谊会会长。入选2014、2015、2016、2017年全球高被引科学家名单。
Tan Weihong
Expert in analytical chemistry and chemical biology，PhD at the University of Michigan，Academician of the Chinese Academy of Sciences and Academician of the Academy of Developing Countries，Chief Scientist of "973" project，Distinguished Professor of Yangtze River Scholar, Distinguished Professor of National “Thousand Talents Program”, Winner of The National Science Fund for Distinguished Young Scholars (B), Vice President of Hunan University; Founder, Dean and Professor of College of Biology, Hunan University; Professor of College of Chemistry and Chemical Engineering, Hunan University; Professor of Frontiers in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences; Dean of the Institute of Molecular Medicine, Shanghai Jiao Tong University; Distinguished Professor, V.T. Louise Jackson Professor of Chemistry of University of Florida; Director of the State Key Laboratory of Chemical Biosensing and Metrology (Hunan University); Director of the Hong Kong Baptist University Division of State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University; Leader of the Chemical Biology Innovation Initiative Base (111 Program), Director of the Collaborative Innovation Center for Chemistry and Molecular Medicine, Editor-in-Chief of Analytical Chemistry Frontier, Associate Editor of the Journal of the American Chemical Society (JACS), Vice Chairman of the 10th Provincial Committee of the Hunan Association for Science and Technology, and President of the Hunan Academician Association. Listed as global Highly Cited Scientists in 2014, 2015, 2016 and 2017.
Vidal Puig教授 英国医学科学院 院士
学术委员会委员Member of the Academic Council
英国医学科学院 院士 Fellow Academy of Medical Sciences
剑桥大学分子营养和代谢生物学教授Professor of Nutrition and Metabolism at the University of Cambridge
西班牙瓦伦西亚大学医学院 医学博士MD, Valencia University of Medicine
格拉纳达大学医学院 哲学博士 PhD，Granada University School of Medicine
Vidal Puig教授是剑桥大学分子营养和代谢生物学教授，主要从事肥胖与胰岛素抵抗相关性的分子机制、糖尿病与心脏代谢异常并发症的分子机制以及相关的药物干预策略研究。在Nature、Cell、Nature Medicine、Nature Genetics、Cell Metabolism、Hepatology和Circulation等国际权威杂志上发表论文170余篇论文。担任Diabetes、Biochemical Journal、Trends Endocrinology and Metabolism、Biochim Biophys Acta和PLoS Biology等国际权威期刊的编委。
Professor Vidal-Puig is the professor of nutrition and metabolism at the University of Cambridge. He mainly engaged in the molecular mechanism of obesity and insulin resistance, the molecular mechanism of diabetes, abnormal cardiac metabolic complications and related drug intervention strategies. He has published more than 170 papers in international prestigious journals such as Nature, Cell, Nature Medicine, Nature Genetics, Cell Metabolism, Hepatology and Circulation. He is the member of the editorial board of international high impact journals such as Diabetes, Journal of Biochemistry, Trend Endocrinology and Metabolism, Biochim Biophys Acta and PLoS Biology.
高绍荣 教授 副院长兼学术委员会委员
中国科学院动物研究所博士，同济大学生命科学与技术学院院长、转化医学高等研究院副院长、国家自然科学基金杰出青年项目获得者、教育部“长江学者”特聘教授、科技部中青年科技创新领军人才、国家 “万人计划”领军人才。2011年获得周光召基金会杰出青年基础科学奖；2014年获国家自然科学奖二等奖；2015年获得谈家桢生命科学创新奖；2015年被授予“有突出贡献中青年专家”荣誉称号。
Prof. ShaoRong Gao, Associate Director, Member of the Academic Council
Ph.D., Institute of Zoology, Chinese Academy of Sciences
Director, School of Life Sciences and Technology, Tongji University
Associate Director, Institute for Translational Medicine Advanced Study, Tongji University
Winner of the National Science Fund for Distinguished Young Scholars
Prof. ShaoRong Gao was granted the title of Distinguished Professor of "Changjiang Scholars" by Ministry of Education, of Leading Talents of Science and Technology Innovation for the Young and Middle-aged, and of Leading Talents for National Ten-thousand Talents Program. He was also awarded Outstanding Youth Basic Science Award by Zhou GuangZhao Foundation in 2011, and the second-class prize of National Natural Science Award in 2014. In 2015, he received the Tan JiaZhen Life Science Innovation Award. He was also awarded the honorary title of "The Young and Middle-aged Experts with Outstanding Contributions" in the same year. He’s now Associate Director and Member of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
何建行 教授 学术委员会委员
广东省心血管病研究所博士
广州医科大学附属第一医院院长，博士生导师
国家呼吸疾病临床医学研究中心副主任
美国及英国外科医师学会会员
广东省医学会胸外科分会首届主任委员、广东省胸部疾病学会会长，国家重点实验室肺癌组学术带头人，国务院特殊津贴专家、卫生部有突出贡献中青年专家、南粤百杰、中国十大口碑医师。获得省部级以上科技进步奖5次，申请授权专利共35项，其中国际发明专利3项。
Prof. JianXing He, Member and Consultant of the Academic Council
Ph.D., Guangdong Cardiovascular Institute
Director and Doctoral Supervisor, The First Affiliated Hospital of Guangzhou Medical University
Deputy Director, National Clinical Research Center for Respiratory Disease
Fellow of the American College of Surgeons and Royal Collage of Surgeons.
He is the first chairman of the thoracic surgery Sub-Chamber of the Guangdong Medical Association and the chairman of Guangdong Association of Thoracic Diseases. He is the academic leader of lung cancer group in the State Key Laboratory and an expert granted the special allowance from the State Council. He was awarded the title of young and middle-aged experts with outstanding contribution by the Ministry of Health, “Nanyue Talent of 100” and the title of “Top Ten Trusted Doctors in China”. He has won 5 science and technology progress awards at provincial and higher levels. He has applied for 35 authorized invention patents, including 3 PCT patents. He’s now Member and Consultant of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
Vidal Puig教授 学术委员会委员
英国医学科学院 院士
剑桥大学分子营养和代谢生物学教授
西班牙瓦伦西亚大学医学院 医学博士
格拉纳达大学医学院 哲学博士
Vidal Puig教授是剑桥大学分子营养和代谢生物学教授，主要从事肥胖与胰岛素抵抗相关性的分子机制、糖尿病与心脏代谢异常并发症的分子机制以及相关的药物干预策略研究。在Nature、Cell、Nature Medicine、Nature Genetics、Cell Metabolism、Hepatology和Circulation等国际权威杂志上发表论文170余篇论文。担任Diabetes、Biochemical Journal、Trends Endocrinology and Metabolism、Biochim Biophys Acta和PLoS Biology等国际权威期刊的编委。
Fellow Academy of Medical Sciences
Professor of Nutrition and Metabolism at the University of Cambridge
MD, Valencia University of Medicine
PhD，Granada University School of Medicine
Prof.Antonio Vidal-Puig,Member of the Academic Council
Professor Vidal-Puig is the professor of nutrition and metabolism at the University of Cambridge. He mainly engaged in the molecular mechanism of obesity and insulin resistance, the molecular mechanism of diabetes, abnormal cardiac metabolic complications and related drug intervention strategies. He has published more than 170 papers in international prestigious journals such as Nature, Cell, Nature Medicine, Nature Genetics, Cell Metabolism, Hepatology and Circulation. He is the member of the editorial board of international high impact journals such as Diabetes, Journal of Biochemistry, Trend Endocrinology and Metabolism, Biochim Biophys Acta and PLoS Biology.
康铁邦 教授 学术委员会委员
博士、教授、博士生导师，教育部“长江学者”特聘教授（2015.01--2019.12），国家杰出青年科学基金获得者（2011年）。现任中山大学肿瘤防治中心实验研究部副主任，华南肿瘤学国家重点实验室PI，中国细胞生物学学会肿瘤细胞生物学分会副会长，中国抗癌协会肿瘤病因专业委员会副主任委员。2003年，获德国Bielefeld大学生物化学博士学位。1998---2008年，一直在美国、德国从事细胞生物学、肿瘤学研究工作。2008年5月，全职回国（中山大学“百人计划”引进人才）。已获得国家自然科学基金重点项目2项、“973”计划项目（2项）、国家肝癌重大专项基金（1项）、国家重点研发计划（2项）。通讯或第一作者在Cancer Cell, J Clin Invest, Cell Res, J Natl Cancer Inst, Nucleic Acids Res, Cancer Res, Clin Cancer Res, Oncogene, J Pathol, J Biol Chem 等国际主流杂志上发表论著40篇。研究方向：肿瘤转移的调控、肿瘤耐药的机制与干预等．
Prof.TieBang Kang,Member of the Academic Ciuncil
PhD, Professor, PhD Supervisor, Distinguished Professor of the Yangtze River Scholar of the Ministry of Education (2015.01---2019.12), Winner of the National Science Fund for Distinguished Young Scholars (2011). He is currently the deputy director of the Experimental Research Department of the Cancer Center of Sun Yat-sen University, the PI of State Key Laboratory of Oncology in South China, the Vice President of the Cancer Cell Biology Branch of the Chinese Society for Cell Biology, and the Vice Chairman of the Cancer Cause Committee of the China Anti-Cancer Association. In 2003, he received his Ph.D. in biochemistry from the University of Bielefeld, Germany. From 1998 to 2008, he has been engaged in cell biology, oncology research in the United States of America and Germany. In May 2008, he returned to China with a full-time job (the “Hundred Talents Program” of Sun Yat-sen University introduced talents). He has received 2 key projects from National Natural Science Foundation of China, “973” plan project (2 items), National Liver Cancer Major Fund (1 item), and National Key Research and Development Project (2 items). He has published 40 articles in international mainstream journals such as Cancer Cell, J Clin Invest, Cell Res, J Natl Cancer Inst, Nucleic Acids Res, Cancer Res, Clin Cancer Res, Oncogene, J Pathol, J Biol Chem as the corresponding author or first author. Research direction: regulation of tumor metastasis, mechanism and intervention of tumor resistance.
康九红 教授 副院长兼学术委员会委员
兰州大学细胞生物学专业理学博士学位，同济大学生命科学与技术学院特聘教授、党委书记。2011年，作为首席科学家获得国家科技部“干细胞研究”重大科研计划项目；作为负责人获得教育部创新团队发展计划资助；2013年，当选科技部中青年科技创新领军人才，获国务院政府特殊津贴。2016年获国家科技部“干细胞基础及转化研究”重大研发计划首席科学家。中国细胞生物学会医学细胞生物学会理事，中国解剖学会医学发育生物学分会副理事长。
Prof. JiuHong Kang, Associate Director, Member of the Academic Council
Ph.D., Cell Biology, Lanzhou University
Distinguished Professor, Secretary to the Party Committee, School of Life Sciences and Technology, Tongji University
In 2011, as the chief scientist, Prof. JiuHong Kang undertook the major scientific research project of the Ministry of Science and Technology on Stem Cell Research. He was also in charged of the Innovation Team Development Program funded by Ministry of Education. In 2013, he was selected as the Leading Talents for the Young and Middle-aged Science and Technology Innovation Program of Ministry of Science and Technology, for which he was entitled to special allowance from government by the State Council.
In 2016, he was selected as the Leading Scientist for the major research and development Program on Stem Cell Foundation and Transformation Research by the Ministry of Science and Technology. He is now Director of the Chinese Society for Cell Biology and the Medical Society for Cell Biology, and Vice Chairman of the Medical Developmental Biology Sub-Chamber of the Chinese Society For Anatomical Sciences. He’s now Associate Director and Member of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
李治寰 联合创始人、院长兼学术委员会委员
清华大学本科，美国罗切斯特大学博士，耶鲁大学、哈佛大学博士后，中国科学院深圳先进技术研究院客座研究员。曾获美国罗切斯特大学优秀博士论文以及美国遗传学会Larry Sandler奖第二名，2017年入选深圳市海外高层次人才“孔雀计划”，具有国内外顶尖学术背景和产业资本运作经验。
Dr. ZhiHuan Li, Co-Founder, Director, Member of the Academic Council
B.S., Tsinghua University
Ph.D., University of Rochester, USA
Post-doctoral, Yale University & Harvard University, USA
He was awarded commendation in the Outstanding Thesis Award competition of the University of Rochester in 2014 and was the runner-up of Larry Sandler Award of the Genetics Society of America in 2015. He has applied for 5 invention patents. In 2017, he returned to China and was listed as the Overseas High-Caliber Personnel by Shenzhen City. In 2018, he was awarded “Outstanding Investor” by the Chinese Academy of Sciences Venture Capital. In 2019, he was appointed as a director of the Tsinghua University Alumni Association in Life Sciences. Dr. Li has premium academic background and industrial capital experience. He’s now Co-Founder, Director and Member of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
阮建波 教授 副总经理兼副院长
皮肤性病学主任医师、东莞市名医、硕士研究生导师以及东莞市特色人才。现任广东省中西医结合学会慢性皮肤病防治专业委员会常务委员、广东省医学会皮肤性病分会和男科分会委员、广东省医师协会皮肤科医师分会委员、东莞市皮肤性病学分会副主任委员。
Prof. JianBo Ruan, Partner, Vice General Manager, Associate Director
Chief Physician of Dermatology and Venerology, Famous Doctor in Dongguan, Master Tutor, Dongguan Distinguished Talents
He is currently a standing committee of the Chronic Skin Diseases Prevention and Treatment Committee of Guangdong Association of Chinese Integrative Medicine, a member of the Dermatology and Andrology Sub-Chamber of Guangdong Medical Association, a member of the Dermatology Sub-Chamber of Guangdong Medical Doctor Association and the Deputy Director of Dongguan Dermatology Sub-Chamber He’s now Partner, Vice General Manager and Associate Director of Dongguan Enlife Stem Cell Biotechnology Institute.
郑辉 研究员 副院长兼学术委员会委员
清华大学本科，美国明尼苏达大学博士，中国科学院广州生物医药与健康研究院研究员、博士生导师。国家自然科学基金优秀青年科学基金获得者。参与完成的《EMT-MET的细胞命运调控》项目获2018年国家自然科学奖二等奖，获得2017年中国科学院杰出科技成就奖（7/17）。
R. Hui Zheng, Associate Director, Member of the Academic Council
B.S., Tsinghua University
Ph.D., University of Minnesota, USA
Professor and Doctoral Supervisor, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences.
R. Hui Zheng was granted Outstanding Youth Science Foundation by the National Natural Science Foundation of China. He also participated in the "EMT-MET Cell Fate Regulation" Project, which won the second class prize of the 2018 National Natural Science Award, and the 2017 Outstanding Science and Technology Achievement Prize (7/17) of the Chinese Academy of Sciences. He’s now Associate Director and Member of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
畅君雷 研究员 学术委员会顾问
清华大学本科，美国哈佛医学院博士，中国科学院深圳先进技术研究院研究员、博士生导师。畅君雷研究员为中科院百人计划C类人才候选人，2017年入选深圳市海外高层次人才 “孔雀计划”B类。在国际一流权威SCI学术刊物上发表论文13篇，文章总影响因子近260总引用次数近300次。
R.JunLei Chang, Consultant of the Academic Council
B.S., Tsinghua University
Ph.D., Harvard Medical School, USA
Researcher and Doctoral Supervisor,
JunLei Chang is a Type C talent candidate for the Hundred-Talents Project of Chinese Academy of Sciences. In 2017, he was selected as Overseas High-Caliber Personnel (Type B). He has published 13 papers in the world's leading SCI authorized academic journals. The total impact factor of the papers is close to 260 with nearly 300 citations. He’s now Consultant of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
万晓春 研究员 学术委员会顾问
加拿大蒙特利尔大学博士，中国科学院深圳先进技术研究院生物医药与技术研究所副所长、医药所抗体药物研究中心执行主任、博士生导师。2013年入选深圳市海外高层次人才 “孔雀计划”B类、2015年入选中国科学院特聘研究员特聘骨干人才。承担国家、广东省、深圳市等各级科研项目13项，总项目经费达7920万元；共申请专利90余项，其中获批发明专利10项、实用新型专利1项。
R.XiaoChun Wan, Consultant of the Academic Council
Ph.D., University of Montreal, Canada
Deputy Director, Institute of Bio-medicinal Technology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences Executive Director and Doctoral Supervisor, Antibody Drug Discovery Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
In 2013, he was selected as Overseas High-Caliber Personnel (Type B), and in 2015 Distinguished Researcher of the Chinese Academy of Sciences. While undertaking 13 scientific research projects at National, Provincial and Municipal level, he managed research funds that amounts to 79.2 million RMB, from which over 90 patent applications have been generated, including 10 invention patents and 1 practical patent. He’s now Consultant of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
林同香 教授 学术委员会顾问
美国加州大学圣地亚哥分校博士后，美国Scripps研究所助理研究员。现任福建农林大学教授，博士生导师, 闽江学者特聘教授，世界中医药学会联合会中药新药创制专业委员会理事、广东省帕金森病及运动专业委员会理事、广东省药理学会药物代谢专业委员会常委。
Prof. TongXiang Lin, Member of the Academic Council
Postdoctoral Fellow, University of California, San Diego
Assistant Research Fellow, Scripps Research Institute, USA.
He is currently a professor at Fujian Agriculture and Forestry University, a doctoral tutor, a special professor of Minjiang Scholars, a member of the World Federation of Chinese Medicine Societies, a member of the Professional Committee for New Traditional Drugs Development, a member of the Guangdong Parkinson's Disease and Sports Professional Committee, and a member of the Standing Committee of the Drug Metabolism Committee of the Guangdong Pharmacological Society. He’s now Member of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
陈志凌 博士 学术委员会委员
苏黎世联邦理学院（瑞士）、 欧洲核子研究中 (CERN) 博士
中国科学院上海应物理研究所/上海等研究院正研级
上海市“台国产质 治疗示范装置”副总 程师
中国科学院“百 计划”技术英才
Dr. ZhiLing Chen, Member of the Academic Council
Ph.D., ETH Zurish, Switzerland
Ph.D., the European Centre for Nuclear Research (CERN)
Senior Research Engineer, Shanghai Institute of Applied Physics, Chinese Academy of Sciences/Shanghai Research Institute
Deputy Chief Engineer, “the First Homemade Proton Therapy Demonstration Device” in Shanghai
Technical Talents, “Hundred-Talents Program” of Chinese Academy of Sciences
Member of the Academic Council, Dongguan Enlife Stem Cell Biotechnology Institute.
张书彦 教授 顾问
牛津大学 博士
英国卢瑟福•阿普尔顿实验室 博士后
曾任英国散裂中子源首席科学家
广东（东莞）材料基因高等理工研究院 院长
第十三届广东省人大代表
东莞市恩联干细胞生物科技研究院顾问
Dr. ShuYan Zhang, Consultant
Ph.D., Oxford University
Post-doctoral, Rutherford Appleton Laboratory, UK
Former Chief Scientist, Spallation Neutron Source of UK
Director, Centre of Excellence for Advanced Materials
Representative of the 13th Guangdong Provincial People's Congress Consultant, Dongguan Enlife Stem Cell Biotechnology Institute
楼陆军 副主任 学术委员会委员
南部战区空军医院专家组成员。原南部战区空军医院药剂科主任。从事药学专业38年，具有丰富的药学理论知识和实践经验，发表论文多篇，获军队科技进步奖多项，多年担任广州军区专家组成员，现为南部战区空军医院专家组成员。入伍40年荣立三等功三次。
Dr. LuJun Lou, Member of the Academic Council
Member of the Expert Group of the Southern Theater Air Force Hospital. Former director of the Pharmacy Department of the Southern Theater Air Force Hospital. He has been engaged in pharmacy for 38 years and has rich theory knowledge and practical experience in pharmacy. He has published many papers and won a number of awards for military science and technology progress. He has served as a member of the Guangzhou Military Region Expert Group for many years and is now a member of the Expert Team of the Southern Theater Air Force Hospital. In the 40 years of enlistment, he won three third-class merits. He’s now Member of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
贾文文 博士 学术委员会委员
西北农林科技大学学士和硕士，西北农林科技大学和美国宾夕法尼亚大学联合培养博士。现任同济大学附属第一妇婴保健院转化医学研究中心副研究员，东方医院GMP实验室主任。
Dr. WenWen Jia, Member of the Academic Council
B.S. and M.S., Northwest A&F University
Ph.D., Northwest A&F University and University of Pennsylvania.
Dr. Wenwen Jia is currently an associate professor at the Translational Medical Research Center of the Shanghai First Maternal and Infant Hospital affiliated to Tongji University, Director of the GMP Laboratory of the Oriental Hospital and Member of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
刘星吟 教授 学术委员会委员
中山大学 博士
美国罗切斯特大学、爱因斯坦医学院 博士后
江苏省特聘医学专家，江苏省特聘教授
南京医科大学生殖医学国家重点实验室孤独症研究中心副主任
南京医科大学生殖医学国家重点实验室副主任
南京医科大学整合肠病学重点实验室执行主任
南京医科大学肠道微生态创新团队组长
Prof. XingYin Liu, Member of the Academic Council
Ph.D., Zhongshan University
Post-doctoral, University of Rochester, USA & Albert Einstein College of Medicine
Distinguished Expert and Professor in Jiangsu Province
Deputy Director, Autism Research Center of State Key Laboratory of Reproductive Medicine, Nanjing Medical University
Deputy Director, State Key Laboratory of Reproductive Medicine, Nanjing Medical University
Executive Director, Key Laboratory of Integrated Enterology, Nanjing Medical University
Leader, Intestinal Microecology Innovation Team, Nanjing Medical University
Member of the Academic Council, Dongguan Enlife Stem Cell Biotechnology Institute.
罗伯特·K·诺曼 研究员 学术委员会顾问
德国柏林洪堡大学博士
德国法兰克福马克斯普朗克脑研究所博士后
中国科学院深圳先进技术研究院研究员
2018年入选海外高级人才（B级）。他在包括Science，Neuron和Current Biology的出版物上发表了16篇研究论文，总被引用超过400次。
Robert K. Naumann, Consultant of the Academic Council
PhD, Humboldt-University, Berlin, Germany
PostDoc, Max Planck Institute for Brain Research, Frankfurt, Germany
Professor, Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences
Robert K. Naumann was selected as Overseas High-Caliber Personnel (Level B) in 2018. He has published 16 research papers including publications in Science, Neuron, and Current Biology. In total his papers have been cited more than 400 times. He is now a Consultant of the Academic Council of Dongguan Enlife Stem Cell Biotechnology Institute.
林立龙 科研主任
中国科学院广州生物医药与健康研究院 博士
广东省科学技术二等奖
LiLong Lin, Principal Investigator
Ph.D., Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
刘冬羽 研发副主任
北京协和医学院–清华大学医学部 硕士
DongYu Liu, Assistant Principal Investigator
M.S., Peking Union Medical College-Tsinghua University School of Medicine
网站留言
官网“客户中心”——“联系我们”留言您的联系方式和需求，专属客服收到资料后将尽快与您联系。
电话咨询
致电服务热线0769-28828333，将有专属客服为您服务。
公众号咨询
搜索“粤港澳干细胞”公众号关注留言您的联系方式等信息，我们将第一时间与您联系。
Copyright © 粤港澳干细胞生物科技有限公司All Rights Reserved. 粤ICP备19082248号 网站地图
